We have merged with Sobi AB creating a biopharma company positioned to provide innovative medicines that transform the lives of people with rare and debilitating diseases. Visit www.sobi.com to continue to learn more about our work. For more information on the acquisition, see our press release at: https://bit.ly/42XKW9M